Creative Planning
ORIC icon

Creative Planning’s Oric Pharmaceuticals ORIC Stock Holding History

Creative Planning’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
29,903
+13,437
+82% +$122K ﹤0.01% 3513
2026
Q1 		$209K Buy
16,466
+1,692
+11% +$19.2K ﹤0.01% 3698
2025
Q4 		$121K Sell
14,774
-2,920
-17% -$33.6K ﹤0.01% 3682
2025
Q3 		$212K Buy
17,694
+6,599
+59% +$69.4K ﹤0.01% 3429
2025
Q2 		$113K Buy
+11,095
New +$74.5K ﹤0.01% 3398
2024
Q4 		– Sell
-11,272
Closed -$116K – 3655
2024
Q3 		$116K Buy
+11,272
New +$111K ﹤0.01% 2986

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning's ORIC Position: Q2 2026 in Review

Creative Planning increased its Oric Pharmaceuticals (ORIC) stake by 82% in Q2 2026, buying an estimated $122K and bringing the position to 29,903 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Creative Planning first reported a position in ORIC in Q3 2024 and has held it in 6 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Creative Planning held 29,903 shares of Oric Pharmaceuticals worth $324K as of Q2 2026.
  • Creative Planning bought 13,437 Oric Pharmaceuticals shares in Q2 2026, an estimated $122K.
  • Oric Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3513 holding.
  • Creative Planning first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.